Hillhouse Capital Management - Q2 2018 holdings

$5.87 Billion is the total value of Hillhouse Capital Management's 54 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 41.7% .

 Value Shares↓ Weighting
BABA BuyALIBABA GROUP HLDG LTDsponsored ads$1,207,511,000
+323.3%
6,508,438
+318.7%
20.58%
+308.9%
BGNE  BEIGENE LTDsponsored adr$841,250,000
-8.5%
5,472,2590.0%14.34%
-11.6%
JD SellJD COM INCspon adr cl a$826,212,000
-41.9%
21,212,125
-39.6%
14.08%
-43.9%
WUBA Sell58 COM INCspon adr rep a$370,877,000
-16.3%
5,348,673
-3.6%
6.32%
-19.2%
ESGR SellENSTAR GROUP LIMITED$362,327,000
-11.6%
1,747,840
-10.4%
6.18%
-14.6%
FGEN BuyFIBROGEN INC$168,156,000
+39.9%
2,686,196
+3.2%
2.87%
+35.1%
MLCO SellMELCO RESORT ENTERTAINMENT Ladr$148,923,000
-38.3%
5,318,663
-36.1%
2.54%
-40.4%
MDLZ  MONDELEZ INTL INCcl a$144,700,000
-1.7%
3,529,2640.0%2.47%
-5.1%
SNAP BuySNAP INCcl a$143,853,000
+49.4%
10,989,529
+81.1%
2.45%
+44.3%
EA SellELECTRONIC ARTS INC$114,913,000
-7.8%
814,867
-20.8%
1.96%
-11.0%
IQ SellIQIYI INCsponsored ads$112,271,000
-32.7%
3,475,876
-67.6%
1.91%
-35.0%
BIDU NewBAIDU INCspon adr rep a$108,094,000444,831
+100.0%
1.84%
NFLX  NETFLIX INC$103,514,000
+32.5%
264,4500.0%1.76%
+28.0%
KNSA NewKINIKSA PHARMACEUTICALS LTD$99,529,0005,736,527
+100.0%
1.70%
APLS BuyAPELLIS PHARMACEUTICALS INC$95,222,000
+201.5%
4,328,289
+203.0%
1.62%
+191.4%
YY BuyYY INC$94,701,000
+67.0%
942,575
+74.9%
1.61%
+61.4%
BPMC BuyBLUEPRINT MEDICINES CORP$90,837,000
-27.6%
1,430,949
+4.6%
1.55%
-30.1%
TRIP SellTRIPADVISOR INC$75,758,000
+13.1%
1,359,857
-17.0%
1.29%
+9.2%
BEDU SellBRIGHT SCHOLAR ED HLDGS LTDsponsored ads$71,397,000
+7.5%
4,293,267
-0.2%
1.22%
+3.9%
NTES SellNETEASE INCsponsored adr$66,916,000
-46.8%
264,837
-41.0%
1.14%
-48.6%
CBPO  CHINA BIOLOGIC PRODS HLDGS I$61,425,000
+22.6%
618,3910.0%1.05%
+18.4%
KANG BuyIKANG HEALTHCARE GROUP INCsponsored adr$59,801,000
+7.7%
2,922,834
+5.0%
1.02%
+4.0%
LN BuyLINE CORPsponsored adr$49,603,000
+20.5%
1,207,763
+14.5%
0.84%
+16.4%
NOAH NewNOAH HLDGS LTDspon ads cl a$46,515,000891,942
+100.0%
0.79%
MYOK BuyMYOKARDIA INC$42,617,000
+15.2%
858,340
+13.2%
0.73%
+11.2%
TAL SellTAL ED GROUPsponsored ads$34,001,000
-62.2%
923,933
-61.9%
0.58%
-63.4%
XLRN  ACCELERON PHARMA INC$33,964,000
+24.1%
700,0000.0%0.58%
+19.9%
GTHX  G1 THERAPEUTICS INC$30,397,000
+17.3%
699,4310.0%0.52%
+13.3%
SOHU NewSOHU COM LTDsponsored ads$28,472,000802,034
+100.0%
0.48%
FB NewFACEBOOK INCcl a$23,175,000119,261
+100.0%
0.40%
UXIN NewUXIN LTDads$22,600,0002,500,000
+100.0%
0.38%
MCO  MOODYS CORP$15,342,000
+5.7%
89,9490.0%0.26%
+2.0%
BRKA  BERKSHIRE HATHAWAY INC DELcl a$14,384,000
-5.7%
510.0%0.24%
-8.9%
LOXO NewLOXO ONCOLOGY INC$14,104,00081,300
+100.0%
0.24%
SCHW  SCHWAB CHARLES CORP NEW$13,890,000
-2.1%
271,8260.0%0.24%
-5.2%
NEW NewPUXIN LTDads$13,454,000628,673
+100.0%
0.23%
LBTYK SellLIBERTY GLOBAL PLC$12,587,000
-16.1%
473,034
-4.0%
0.22%
-18.9%
VRSN  VERISIGN INC$10,404,000
+15.9%
75,7110.0%0.18%
+12.0%
GSAHU NewGS ACQUISITION HLDGS CORPunit 06/12/2023$10,200,0001,000,000
+100.0%
0.17%
INCY NewINCYTE CORP$9,583,000143,030
+100.0%
0.16%
RCUS BuyARCUS BIOSCIENCES INC$9,390,000
+43.1%
767,128
+80.5%
0.16%
+37.9%
NTGN NewNEON THERAPEUTICS INC$8,969,000711,809
+100.0%
0.15%
GHG  GREENTREE HOSPITALTY GROUP Lsponsored ads$7,688,000
+41.9%
425,0000.0%0.13%
+36.5%
IDXX  IDEXX LABS INC$7,275,000
+13.9%
33,3800.0%0.12%
+9.7%
CJJD NewCHINA JO-JO DRUGSTORES INC$6,970,0004,840,000
+100.0%
0.12%
SFUN  FANG HLDGS LTDadr$5,820,000
-24.5%
1,500,0000.0%0.10%
-27.2%
NKTR BuyNEKTAR THERAPEUTICS$5,248,000
-4.8%
107,471
+107.2%
0.09%
-8.2%
SPGI  S&P GLOBAL INC$4,972,000
+6.7%
24,3870.0%0.08%
+3.7%
EIDX NewEIDOS THERAPEUTICS INC$4,577,000225,000
+100.0%
0.08%
CI SellCIGNA CORPORATION$3,769,000
-60.0%
22,176
-60.5%
0.06%
-61.4%
SLDB  SOLID BIOSCIENCES INC$2,494,000
+375.0%
70,0000.0%0.04%
+377.8%
SellNABRIVA THERAPEUTICS PLC$2,491,000
-38.3%
715,704
-10.8%
0.04%
-40.8%
PTI  PROTEOSTASIS THERAPEUTICS IN$2,416,000
-41.3%
865,9230.0%0.04%
-43.8%
TSRO  TESARO INC$1,650,000
-22.2%
37,1000.0%0.03%
-24.3%
YUMC ExitYUM CHINA HLDGS INC$0-69,698
-100.0%
-0.05%
CHTR ExitCHARTER COMMUNICATIONS INC Ncl a$0-17,483
-100.0%
-0.10%
SE ExitSEA LTDadr$0-1,444,396
-100.0%
-0.29%
TIG ExitTIGENIXsponsored ads$0-483,870
-100.0%
-0.36%
SOHU ExitSOHU COM INC$0-802,034
-100.0%
-0.44%
BILI ExitBILIBILI INC$0-4,250,000
-100.0%
-0.82%
SINA ExitSINA CORPord$0-1,653,197
-100.0%
-3.04%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MONDELEZ INTL INC22Q3 201844.4%
JD COM INC19Q2 201980.2%
SOHU COM INC19Q1 201813.4%
58 COM INC18Q3 20187.8%
TAL EDUCATION GROUP18Q2 20194.4%
CTRIP COM INTL LTD17Q2 201728.4%
BEIGENE LTD14Q2 201925.2%
MELCO RESORT ENTERTAINMENT L14Q3 20186.4%
CAMECO CORP14Q4 20172.2%
ENSTAR GROUP LIMITED12Q2 201921.9%

View Hillhouse Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Hillhouse Capital Management Q2 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
China Jo-Jo Drugstores Holdings, Inc.February 14, 2023403,3344.7%
TScan Therapeutics, Inc.February 14, 2023? ?
Enfusion, Inc.February 14, 20224,975,1837.6%
Enstar Group LTDJuly 19, 2021? ?
Zoom Video Communications, Inc.February 16, 20212,981,2651.5%
NIO Inc.February 14, 2020? ?
Sea LtdFebruary 14, 20204,300,0002.3%
Uxin LtdFebruary 14, 202021,733,0232.6%
Apellis Pharmaceuticals, Inc.February 14, 20192,098,5813.7%
iQIYI, Inc.February 14, 2019240,191,17411.0%

View Hillhouse Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-03-05
13F-NT2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
42024-02-01
32024-01-25
13F-NT2023-11-14
13F-NT2023-08-14

View Hillhouse Capital Management's complete filings history.

Compare quarters

Export Hillhouse Capital Management's holdings